IEG Policy is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Daniel Willis

Set Alert for Articles By Daniel Willis

Latest From Daniel Willis

Kane, Dechra expand distribution agreement to South America

Canadian firm Kane Biotech and Dechra Pharmaceuticals have expanded their licence and distribution agreement to include South America.

South America Dechra Pharmaceuticals

Zoetis reaches another share price high following CEO appointment

Zoetis has yet again seen its share value climb to its highest ever level.


Texas Tech awarded USDA-NIFA grant to target cattle infection

A Texas Tech University (TTU) professor has received a $464,338 grant to examine the underlying factors associated with metritis – a bacterial infection that affects dairy cattle.

Research Investments

Kane bags R&D funding from Canadian research council

Kane Biotech has been awarded funding of Can$340,680 ($258,579) from the National Research Council of Canada's Industrial Research Assistance program (NRC-IRAP).

Canada R&D

Holk Nielsen to step down as Novozymes CEO

Peder Holk Nielsen will leave the positions of president and chief executive of Danish firm Novozymes in early 2020.


Wageningen studies reveal zinc benefit in piglets post-weaning

Research by Wageningen Livestock Research (WLR) has indicated providing a high zinc diet to piglets during post-weaning can modulate gut microbiota composition and intestinal function.

Porcine Feed & Additives
See All